Not checkedNot checked for notices yet.

The iron chelator deferoxamine decreases myeloma cell survival

Feifei Yang, Zhaoxian Wu, Dan Dai and 4 more

Journal of International Medical Research · 2021

doi:10.1177/0300060520987396 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

References41

11.
Iron Homeostasis in Health and Disease · 2016
12.
A Review on Iron Chelators in Treatment of Iron Overload Syndromes. · 2016
24.
Iron in the Tumor Microenvironment—Connecting the Dots · 2018
25.
Iron Metabolism in Cancer · 2018
26.
Iron as a Central Player and Promising Target in Cancer Progression · 2019
37.
Corrected
IMCA Induces Ferroptosis Mediated by SLC7A11 through the AMPK/mTOR Pathway in Colorectal Cancer · 2020
38.
Altered Iron Metabolism and Impact in Cancer Biology, Metastasis, and Immunology · 2020

34 more references, whose wording the paper’s licence keeps private.

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.